Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0320
-0.0036 (-10.11%)
At close: Oct 1, 2026
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $3.36 million as of October 1, 2026. Its market cap has decreased by -39.37% in one year.
Market Cap
3.36M
Enterprise Value
9.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
ChartMarket Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 3.36M, a decrease of -97.15%. That is a compound annual growth rate of -11.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 3.36M | -18.06% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EOM Pharmaceuticals Holdings | 14.44M |
| Synlogic | 14.09M |
| ZIVO Bioscience | 13.70M |
| Anebulo Pharmaceuticals | 13.05M |
| Zeo ScientifiX | 11.44M |
| Hepion Pharmaceuticals | 10.80M |
| Oncotelic Therapeutics | 10.75M |
| Brainstorm Cell Therapeutics | 10.15M |